VP, HEOR Immunology

Employer
AbbVie
Location
Lake County, IL, US
Posted
Oct 08, 2018
Ref
1805683
Required Education
Doctorate/PHD/MD
Position Type
Full time
VP, HEOR Immunology is accountable for the execution of strategic plans for all AbbVie's Immunology products to obtain and maintain market access,favorable pricing and optimal formulary status; and ensuring that the strategic plans are consistently relevant to product development and the marketplace. VP is responsible for executing HEOR strategies which have global responsibility for demonstrating the economic, humanistic, and patient value proposition of AbbVie' s pharmaceutical products in the pipeline and on the market.

The position will maximize the value of AbbVie' s compounds by providing the global clinical, epidemiology and economic data evidence as well as associated tools to obtain and maintain market access, optimal formulary status and pricing as well increase the global market uptake of all AbbVie products. The position will influence and guide Area and Affiliate functions in developing consistent strategies for addressing market/ payer reimbursement hurdles

Key Responsibilities Include:

  • The VP drives the design, execution, and analysis of strategies for all Immunology products in the pipeline and on the market and for driving budget allocation to meet business imperatives.
  • Develop and execute HEOR product life-cycle, market uptake and labeling strategies with VP, HEOR while integrating the needs of internal and external stakeholders. Establishes HEOR goals in conjunction with team members and all inter-project priorities to meet business strategies.
  • Ensures that goals are met within allotted time.
  • Drive execution of strategic global research plans for all drugs in development as well as on the market.
  • Direct the design and execution of the worldwide HEOR development plans of the New Product Development (NDPs).
  • Develop, organize, implement, and integrate the HEOR strategy to allow the development of each NDP to proceed expeditiously and efficiently toward registration, PR&A and market launch to ensure compliance with national and international governmental regulations for all products.
  • Influence and provide guidance and counsel to Sr. leadership across AbbVie, include Therapeutic Area Teams (TAT) on pipeline compounds and on-market products for all therapeutic areas.
  • Ensure that evidence for all New Drug Products (NDPs) is provided at the right time and integrated with clinical and non-clinical data for PLT Milestone decision-making.
  • Develops and coaches staff and team in the management of the development and registration, market access and launch of NDPs and successful HEOR strategic support of commercial teams in the post-approval setting.
  • Provide leadership for NDP HEOR development aspects, establishing the high standards required to obtain registration (e.g., PRO labeling claim), PR&A approvals in the shortest possible time. Manage complex scientific and PR&A issues requiring scientific/technical expertise as well as skills in marketing, etc. Assume full scientific HEOR strategic support of commercialization activities including the facilitation of achieving and maintaining market access and growing the market
  • Establish and maintain effective and timely multi-directional communication within the TEC, cross functional product/brand/asset teams, internal governance committees, functional area management, Area management etc. Track progress of execution of HEOR development and in-line product programs in terms of deliverables, timelines, and budget.
  • Actively coach, provide, and solicit feedback cross functionally to build a cohesive and motivated team to drive superior execution and high quality deliverables.
  • Directs all HEOR programs in support of the Clinical development of NDPs throughout Phases I, II and III, and post-launch, including patient-segmentation strategies.
  • Design and implement processes to ensure collaboration and timely execution of projects within budget.


Basic:

  • Doctoral Degree: Economics, Public Health, Psychology or any other related field with 12-15 years of relevant experience, preferred.
  • MD or PharmD, with a Masters or Doctorate in Economics, Public Health, Psychology or any other related field with at least 15 years of relevant experience
  • 12-15 years of clinical development or post-marketing experience in the pharmaceutical industry is desired. CRO, academic or other health-related consulting company experience with expert knowledge in a relevant therapeutic specialty will be considered.
  • The VP must perform at times in previously uncharted territory with few, if any, established guidelines or procedures. At other times, exceedingly complex governmental rules and regulations must be followed. For problems surrounded by complex rules and regulations, the VP must be able to direct compliance knowledgeably and expeditiously. Delete
  • Proven leadership skills in a cross-functional global team environment. Ability to interact externally and internally to support global business strategy. Interact successfully with senior management globally (Executive staff, Area VPs, GMs etc.) and act as the HEOR champion and spokesperson
  • The VP must be able to develop creative and effective solutions to inter- and intra-project priority conflicts, resource constraints and other problems which may impact project or group goals and deliverables across multiple programs
  • Experience leading complex products and/or clinical development in support of pipeline development and on-market product support. The VP must be self-motivated and have a strong desire to see projects achieve commercial success. VP should have extensive knowledge of the global regulatory, HTA and PR&A landscape, as well as understanding of other development-related functions as they relate to all phases of drug development.
  • Skills to perform the dual roles of leading multiple TAs and managing scientific personnel in clinical research. VP should have the ability to motivate and foster team & cross functional collaboration.

Travel:

25% travel